Z-0104-2021 Class III Terminated

Recalled by Roche Diagnostics Operations, Inc. — Indianapolis, IN

FDA device recall Z-0104-2021 was initiated by Roche Diagnostics Operations, Inc. on Aug 27, 2020 and is designated Class III. Reason for recall: Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross… The recall status is terminated (terminated May 22, 2024). Affected quantity: 11963.

Recall details

Product Type
Devices
Report Date
Oct 21, 2020
Initiation Date
Aug 27, 2020
Termination Date
May 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11963

Product description

Albumin Gen.2, Catalog 05166861190

Reason for recall

Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.

Distribution pattern

Domestic distribution nationwide.

Code information

lots 43031001, 43718901

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0104-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0104-2021. Report a data issue: hello@regdatalab.com.